✦ LIBER ✦

Safety and Tolerability of a New Intravenous Immunoglobulin Product (Privigen) Administered at High Infusion Rates

✍ Scribed by CHURCH, J; NELSON, R; WASSERMAN, R; SLEASMAN, J; STEIN, M; BICHLER, J

Book ID: 119280297
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 39 KB
Volume: 121
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2007.12.608

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tolerability of a New 10% Liquid Immunog

Tolerability of a New 10% Liquid Immunoglobulin for Intravenous Use, Privigen®, at Different Infusion Rates

✍ John W. Sleasman; Carla M. Duff; Theresa Dunaway; Mikhail A. Rojavin; Mark R. St 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 156 KB

Safety and tolerability of a novel chrom

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura

✍ James B. Bussel; Kim Hanna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d

Safety and Tolerability Of An Intravenou

Safety and Tolerability Of An Intravenously Administered Alpha1-Proteinase Inhibitor (A1PI) At An Increased Infusion Rate: A Randomized, Rate Control, Placebo-Masked, Crossover Study In Healthy Adults

✍ Haeberle, Adam; Ngo, Leock; Inhaber, Neil; Gelmont, David; Yel, Leman 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 43 KB